Beijing Tiantan Biological Products Stock Forecast for 2023 - 2025 - 2030
Updated on 04/27/2024
Beijing Tiantan Biological Products Stock Forecast and Price Target
Beijing Tiantan Biological Products's stock is projected to advance by 11.59% from the previous closing price if it reaches the average target of ¥31.86 by the year's end, as reputable analysts recently projected. This potential upside is calculated on a high-end estimate of ¥32.00 and a low-end estimate of ¥31.71. Even if not interested in 600161 stock, you may want to be aware of its competitors.
11.59% Upside
Beijing Tiantan Biological Products Fair Value Forecast for 2023 - 2025 - 2030
In the last four years, Beijing Tiantan Biological Products's Price has decreased from ¥20.05 to ¥0.00 – a 100.00% drop. In the next year, analysts believe that Fair Value will reach ¥40.10 – an increase of 100.00%. For the next seven years, the forecast is forFair Value to grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| BAX Stock Forecast | Baxter International Inc | Outperform |
17
|
$40.13 | Buy/Sell | $44.86 | 12.14% |
| 002252 Stock Forecast | Shanghai RAAS Blood Products | Buy |
18
|
¥7.19 | Buy/Sell | ¥9.08 | -2.64% |
| GRF Stock Forecast | Grifols | Outperform |
18
|
8.39€ | Buy/Sell | 18.48€ | 126.46% |
| 002007 Stock Forecast | Hualan Biological Engineering | Outperform |
18
|
¥18.54 | Buy/Sell | ¥25.89 | 40.78% |
| 6833 Stock Forecast | Sinco Pharmaceuticals Holdings | - |
12
|
HK$0.26 | Buy/Sell | HK$0.46 | -100.00% |
Beijing Tiantan Biological Products Revenue Forecast for 2023 - 2025 - 2030
Beijing Tiantan Biological Products's Revenue has seen growth In the last three years, going from ¥3.45B to ¥5.18B – a gain of 50.35% In the following year, 0 experts forecast that Beijing Tiantan Biological Products's Revenue will decrease by 12.48%, to ¥4.53B. In 2030, professionals predict that Beijing Tiantan Biological Products's Revenue will decrease by 12.92%, to ¥4.51B.
.jpg)
Beijing Tiantan Biological Products Dividend per Share Forecast for 2023 - 2025 - 2030
In the last three years, Dividend per Share for Beijing Tiantan Biological Products has grown by 50.00%, going from ¥0.10 to ¥0.15. 1 analysts predict Beijing Tiantan Biological Products's Dividend per Share will decrease by 13.33% in the next year, reaching ¥0.13. Over the next seven years, experts anticipate that Dividend per Share growth for Beijing Tiantan Biological Products will be 29.69%.
Beijing Tiantan Biological Products EBITDA Forecast for 2023 - 2025 - 2030
In the last three years, Beijing Tiantan Biological Products's EBITDA has increased by 65.31%, going from ¥1.18B to ¥1.95B. In the next year, analysts are expecting an increase in EBITDA, predicting it will reach ¥2.60B – an increase of 33.41%. The Beijing Tiantan Biological Products forecast is for EBITDA to reach ¥2.88B or grow by 47.59%.
Beijing Tiantan Biological Products EBIT Forecast for 2023 - 2025 - 2030
In the last three years, Beijing Tiantan Biological Products's EBIT has grown, increasing from ¥1.05B to ¥1.71B – an increase of 62.67%. For next year, the 5 analysts predict EBIT of ¥2.22B, which would mean an increase of 30.22%. Over the next seven years, the pros' prediction is EBITof ¥2.73B, which would mean a seven-year growth forecast of 60.11%.
Beijing Tiantan Biological Products EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last four years, Beijing Tiantan Biological Products's EPS has decreased from ¥0.42 to ¥0.00 – a 100.00% drop. In the next year, analysts believe that EPS will reach ¥0.84 – an increase of 100.00%. For the next seven years, the forecast is forEPS to grow by 100.00%.
Site Navigation
.jpg)